Publications
- First experience with therapy of mycophenolate mofetil in refractory myasthenia gravis2005 | Third Faculty of Medicine
- Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis2001 | First Faculty of Medicine, Third Faculty of Medicine
- High dose immunosuppression with hemopoietic stem cell support in the treatment of multiple sclerosis2000 | First Faculty of Medicine, Central Library of Charles University
- High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis2000 | Central Library of Charles University
- Hematopoietic stem cell transplantation in autoimmune diseases in rheumatology practice2000 | Central Library of Charles University
- Immunoablation and hematopoietic stem cell transplantation in the treatment of multiple sclerosis2000 | Central Library of Charles University
- Moderní farmakoterapie v neurologii2021 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival +12021 | First Faculty of Medicine
- Myasthenia - a dreaded diagnosis? : Everything you need to know about your illness2021 | First Faculty of Medicine
- Myasthenia gravis - early diagnosis and current treatment options2021 | Publication without faculty affiliation
Loading network view...
